Orthopedic Prosthetics Industry Key Companies and Market Growth for Germany by 2020

This new report, “Germany Orthopedic Prosthetics Market Outlook to 2020” provides key market data on the Germany Orthopedic Prosthetics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories Lower Extremity Prosthetics and Upper Extremity Prosthetics.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Orthopedic Prosthetics market wherever available.

The data in the report is derived from dynamic market forecast models. The researcher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

Full report giving a detailed analysis and forecast of Orthopedic Device spread over 31 pages is available at http://www.rnrmarketresearch.com/germany-orthopedic-prosthetics-market-outlook-to-2020-market-report.html .

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

• Market size for Orthopedic Prosthetics market categories Lower Extremity Prosthetics and Upper Extremity Prosthetics..
• Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
• 2012 company shares and distribution shares data for each of the market categories.
• Global corporate-level profiles of key companies operating within the Germany Orthopedic Prosthetics market.
• Key players covered include Otto Bock HealthCare GmbH. Ossur hf., The Ohio Willow Wood Company, medi GmbH & Co. KG and Endolite.

Reasons to buy

• Develop business strategies by identifying the key market segments poised for strong growth in the future.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the market.
• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
• What are the key distribution channels and what’s the most preferred mode of product distribution Identify, understand and capitalize.

Table of Contents

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3

2 Introduction 4
2.1 What Is This Report About? 4
2.2 Orthopedic Prosthetics Market Segmentation 4
2.3 Orthopedic Prosthetics Definitions of Markets Covered in the Report 5

3 Orthopedic Prosthetics Market, Germany 6
3.1 Orthopedic Prosthetics Market, Germany, Revenue ($m), 2005-2012 6
3.2 Orthopedic Prosthetics Market, Germany, Revenue ($m), 2012-2020 8
3.3 Orthopedic Prosthetics Market, Germany, Volume (Units), 2005-2012 10
3.4 Orthopedic Prosthetics Market, Germany, Volume (Units), 2012-2020 12
3.5 Orthopedic Prosthetics Market, Germany, Average Price ($), 2005-2020 14
3.6 Orthopedic Prosthetics Market, Germany, Distribution Share by Revenue ($m), 2011-2012 15
3.7 Orthopedic Prosthetics Market, Germany, Company Share by Revenue ($m), 2011-2012 16

4 Overview of Key Companies in Germany Orthopedic Prosthetics Market 18
4.1 Otto Bock HealthCare GmbH 18
4.1.1 Company Overview 18
4.2 Ossur hf. 18
4.2.1 Company Overview 18
4.3 medi GmbH & Co. KG 18
4.3.1 Company Overview 18
4.4 Endolite 19
4.4.1 Company Overview 19
4.5 The Ohio Willow Wood Company 19
4.5.1 Company Overview 19

5 Orthopedic Prosthetics Market Pipeline Products 20

6 Financial Deals Landscape 21
6.1 Partnerships 21
6.1.1 Ergoresearch Enters Into Distribution Agreement with Proteor For Orthopedic Components 21

7 Appendix 23
7.1 Research Methodology 24
7.1.1 Coverage 24
7.1.2 Secondary Research 24
7.1.3 Primary Research 25
7.1.4 Market Modeling and Forecasting 26
7.1.5 Company Share Analysis 29
7.1.6 Distribution Share Analysis 30
7.2 Expert Panels 30
7.3 the researcher Consulting 31
7.4 Contact Us 31
7.5 Disclaimer 31

List of Tables

Table 1: Orthopedic Prosthetics Market, Germany, Revenue ($m), USD Constant, Historic, 2005-2012 7
Table 2: Orthopedic Prosthetics Market, Germany, Revenue ($m), USD Constant, Forecast, 2012-2020 9
Table 3: Orthopedic Prosthetics Market, Germany, Volume (Units), Historic, 2005-2012 11
Table 4: Orthopedic Prosthetics Market, Germany, Volume (Units), Forecast, 2012-2020 13
Table 5: Orthopedic Prosthetics Market, Germany, Average Price ($), Historic, 2005-2012 14
Table 6: Orthopedic Prosthetics Market, Germany, Average Price ($), Forecast, 2012-2020 14
Table 7: Orthopedic Prosthetics Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2011-2012 15
Table 8: Orthopedic Prosthetics Market, Germany, Company Share by Revenue ($m), USD Constant, 2011-2012 17
Table 9: Orthopedic Prosthetics Market Pipeline Products 20
Table 10: Ergoresearch Enters Into Distribution Agreement With Proteor For Orthopedic Components 21
Table 11: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country 26

List of Figures

Figure 1: Orthopedic Prosthetics Market, Germany, Revenue ($m), USD Constant, Historic, 2005-2012 6
Figure 2: Orthopedic Prosthetics Market, Germany, Revenue ($m), USD Constant, Forecast, 2012-2020 8
Figure 3: Orthopedic Prosthetics Market, Germany, Volume (Units), Historic, 2005-2012 10
Figure 4: Orthopedic Prosthetics Market, Germany, Volume (Units), Forecast, 2012-2020 12
Figure 5: Orthopedic Prosthetics Market, Germany, Company Share (%) 2012 16
Figure 6: The researcher Epidemiology Based Forecasting Model 28
Figure 7: The researcher Capital Equipment Based Forecasting Model 29
Figure 8: Primary Calls Split by Participants 30

The report contains a list of tables and figures describing various market and research related to the industry.

Germany Orthopedic Tools Market by 2020 Growth, Strategy, Competition, Investments

This new report, “Germany Orthopedic Tools Market Outlook to 2020″, provides key market data on the Germany Orthopedic Tools market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories Orthopedic Power Tools and Orthopedic Reamers.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Orthopedic Tools market wherever available.

The data in the report is derived from dynamic market forecast models. The researcher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

Full report giving a detailed analysis and forecast of Orthopedic Device spread over 30 pages is available at http://www.rnrmarketresearch.com/germany-orthopedic-tools-market-outlook-to-2020-market-report.html .

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

• Market size for Orthopedic Tools market categories Orthopedic Power Tools and Orthopedic Reamers.
• Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
• 2012 company shares and distribution shares data for each of the market categories.
• Global corporate-level profiles of key companies operating within the Germany Orthopedic Tools market.
• Key players covered include Stryker Corporation, B. Braun Melsungen AG, DePuy Companies and Smith & Nephew Plc.

Reasons to buy

• Develop business strategies by identifying the key market segments poised for strong growth in the future.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the market.
• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
• What are the key distribution channels and what’s the most preferred mode of product distribution Identify, understand and capitalize.

Table of Contents

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3

2 Introduction 4
2.1 What Is This Report About? 4
2.2 Orthopedic Tools Market Segmentation 4
2.3 Orthopedic Tools Definitions of Markets Covered in the Report 5

3 Orthopedic Tools Market, Germany 6
3.1 Orthopedic Tools Market, Germany, Revenue ($m), 2005-2012 6
3.2 Orthopedic Tools Market, Germany, Revenue ($m), 2012-2020 8
3.3 Orthopedic Tools Market, Germany, Volume (Units), 2005-2012 10
3.4 Orthopedic Tools Market, Germany, Volume (Units), 2012-2020 12
3.5 Orthopedic Tools Market, Germany, Average Price ($), 2005-2020 14
3.6 Orthopedic Tools Market, Germany, Distribution Share by Revenue ($m), 2011-2012 15
3.7 Orthopedic Tools Market, Germany, Company Share by Revenue ($m), 2011-2012 16

4 Overview of Key Companies in Germany Orthopedic Tools Market 18
4.1 Stryker Corporation 18
4.1.1 Company Overview 18
4.2 B. Braun Melsungen AG 18
4.2.1 Company Overview 18
4.3 DePuy Companies 18
4.3.1 Company Overview 18
4.4 Smith & Nephew Plc 19
4.4.1 Company Overview 19

5 Financial Deals Landscape 20
5.1 Partnerships 20
5.1.1 Ergoresearch Enters Into Distribution Agreement with Proteor For Orthopedic Components 20

6 Appendix 22
6.1 Research Methodology 23
6.1.1 Coverage 23
6.1.2 Secondary Research 23
6.1.3 Primary Research 24
6.1.4 Market Modeling and Forecasting 25
6.1.5 Company Share Analysis 28
6.1.6 Distribution Share Analysis 29
6.2 Expert Panels 29
6.3 Consulting 30
6.4 Contact Us 30
6.5 Disclaimer 30

List of Tables

Table 1: Orthopedic Tools Market, Germany, Revenue ($m), USD Constant, Historic, 2005-2012 7
Table 2: Orthopedic Tools Market, Germany, Revenue ($m), USD Constant, Forecast, 2012-2020 9
Table 3: Orthopedic Tools Market, Germany, Volume (Units), Historic, 2005-2012 11
Table 4: Orthopedic Tools Market, Germany, Volume (Units), Forecast, 2012-2020 13
Table 5: Orthopedic Tools Market, Germany, Average Price ($), Historic, 2005-2012 14
Table 6: Orthopedic Tools Market, Germany, Average Price ($), Forecast, 2012-2020 14
Table 7: Orthopedic Tools Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2011-2012 15
Table 8: Orthopedic Tools Market, Germany, Company Share by Revenue ($m), USD Constant, 2011-2012 17
Table 9: Ergoresearch Enters Into Distribution Agreement With Proteor For Orthopedic Components 20
Table 10: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country 25

List of Figures

Figure 1: Orthopedic Tools Market, Germany, Revenue ($m), USD Constant, Historic, 2005-2012 6
Figure 2: Orthopedic Tools Market, Germany, Revenue ($m), USD Constant, Forecast, 2012-2020 8
Figure 3: Orthopedic Tools Market, Germany, Volume (Units), Historic, 2005-2012 10
Figure 4: Orthopedic Tools Market, Germany, Volume (Units), Forecast, 2012-2020 12
Figure 5: Orthopedic Tools Market, Germany, Company Share (%) 2012 16
Figure 6: Researcher Epidemiology Based Forecasting Model 27
Figure 7: Researcher Capital Equipment Based Forecasting Model 28
Figure 8: Primary Calls Split by Participants 29

The report contains a list of tables and figures describing various market and research related to the industry.

Avastin market (Microvascular Complications of Diabetes) development and Industry growth by 2022

The entire market for microvascular complications of diabetes (MCD) diabetic nephropathy, retinopathy, and neuropathy is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the major global barrier in the sparsely populated pipeline. The diabetic retinopathy segment of the market has recently seen rapid uptake of novel anti-VEGF therapies and is experiencing a strong growth. On the other hand, the diabetic neuropathy and nephropathy segments face the barrier in and increasing number of generic competitors.

Avastin (bevacizumab) is a recombinant humanized IgG1 mAb that specifically binds to VEGF-A, thereby preventing the interaction of VEGF-A with its receptors on the surface of endothelial cells. Through VEGF-A inhibition, Avastin inhibits angiogenesis, and is indicated for the adjunctive treatment of metastatic colorectal cancer as well as for other types of cancer.

Full report giving a detailed analysis and forecast spread over 58 pages is available at http://www.rnrmarketresearch.com/avastin-microvascular-complications-of-diabetes-forecast-and-market-analysis-to-2022-market-report.html .

Scope

• Overview of MCD, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
• Detailed information on Avastin including product description, safety and efficacy profiles as well as a SWOT analysis.
• Sales forecast for Avastin for the top seven countries from 2012 to 2022.
• Sales information covered for the US, France, Germany, Italy, Spain, the UK and Japan.

Reasons to buy

• Understand and capitalize by identifying products that are most likely to ensure a robust return
• Stay ahead of the competition by understanding the changing competitive landscape for MCD
• Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
• Make more informed business decisions from insightful and in-depth analysis of Avastin performance
• Obtain sales forecast for Avastin from 2012-2022 in top seven countries (the US, France, Germany, Italy, Spain, the UK and Japan)

Table of Contents

1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 8
1.2 List of Figures 8

2 Introduction 9
2.1 Catalyst 9
2.2 Related Reports 10

3 Disease Overview 12
3.1 Etiology and Pathophysiology 14
3.1.1 Diabetic Nephropathy 14
3.1.2 Diabetic Retinopathy 16
3.1.3 Diabetic Neuropathy 17
3.2 Prognosis 18
3.3 Quality of Life 19
3.4 Symptoms 20

4 Disease Management 21
4.1 Treatment Overview 21
4.1.1 Diagnosis and Referrals 21
4.1.2 Screening 23
4.1.3 Treatment Guidelines 24

5 Competitive Assessment 32
5.1 Overview 32
5.2 Strategic Competitor Assessment 33

Get a Sample of the Report for review and learning at http://www.rnrmarketresearch.com/contacts/request-sample?rname=147160 .

6 Avastin (bevacizumab) 37
6.1 Overview 37
6.2 Efficacy 38
6.3 Safety 39
6.4 SWOT Analysis 40
6.5 Forecast 41

7 Appendix 42
7.1 Bibliography 42
7.2 Abbreviations 47
7.3 Methodology 50
7.4 Forecasting Methodology 50
7.4.1 Diagnosed Patients 50
7.4.2 Percent Drug-Treated Patients 51
7.4.3 General Pricing Assumptions 51
7.4.4 Individual Drug Assumptions 52
7.4.5 Generic Erosion 52
7.5 Physicians and Specialists Included in this Study 53
7.6 About the Authors 55
7.6.1 Analyst II - CVMD 55
7.6.2 Therapy Director - CVMD and Infectious Disease 55
7.6.3 Global Head of Healthcare 56
7.7 About researcher 57
7.8 Disclaimer 57

List of Tables

Table 1: Risk Factors for MCD 14
Table 2: Symptoms of MCD 20
Table 3: Diagnostic Tests and Typical Criteria for MCD 22
Table 4: Treatment Guidelines for MCD 25
Table 5: Most Prescribed Drugs for MCD by Class in the 7MM, 2012 28
Table 6: Leading Drug Treatments for MCD, 2013 35
Table 7: Product Profile - Avastin 38
Table 8: Avastin SWOT Analysis, 2013 40
Table 9: Global Sales Forecasts ($m) for Avastin, 2012-2022 41
Table 10: Number of High-Prescribing Physicians Surveyed 54

List of Figures

Figure 1: Potential Mechanisms of Diabetes-Induced Microvascular Complications 13
Figure 2: General Treatment Algorithms for MCD 26

The report contains a list of tables and figures describing various market and research related to the industry.